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tery disease (CAD).
METHODS Content of signal-joint T cells receptor excision circles (sj-
TREC) in T lymphocytes, a molecular marker of RTEs, were assessed
among CAD patients and age-matched controls. Monochrome multi-
plex quantitative PCR method was used to assess samples’ telomere
length, a known indicator of increased cell division. Neutrophils to
lymphocytes ratio (NLR) was calculated to reﬂect the severity of in-
ﬂammatory status. Patients were grouped according to Gensini score
(GS) tertile (low GS<18; intermediate GS 18-41, high GS >41). Predic-
tive value of sj-TREC for disease status was evaluated according to
ordinary logistic regression models.
RESULTS Average copy numbers of sj-TREC per 106 T lymphocytes
among patients with non-ST-elevation acute coronary syndrome
(NSTACS), stable angina (SA) and controls were 877494, 1222539
and 1803 817, respectively (P<0.001). No signiﬁcant difference of
telomere length was found among three groups. NLR was signiﬁ-
cantly higher in NSTACS patients (3.92.9) than SA patients (2.41.1,
P<0.01) and controls (2.10.9, P<0.001). Negative correlation be-
tween sj-TREC and NLR was uncovered (R¼-0.3312, P<0.0001). Sj-
TREC level between SA and NSTACS patients was signiﬁcantly
different in the 50-64 years cohort (P<0.001), but not in the 65-80
cohort. Sj-TREC level showed a negative correlation with age among
healthy controls (R¼-0.5052, p¼0.0005) and SA patients (R¼-0.5158,
p¼0.005), but not NSTACS patients (R¼-0.1415, P¼0.0991). Content of
sj-TREC in high GS group (GS>41) was most signiﬁcantly reduced than
low GS group (GS <18) (P<0.001). Ordinal logistic regression analysis
revealed that higher sj-TREC level was independently associated with
absence of CAD (OR¼0.35, P<0.001) and low Gensini score (OR¼0.21,
P<0.001).
CONCLUSIONS Signiﬁcantly reduced sj-TREC level in SA and NSTACS
patients mainly resulted from decreased thymic output rather than
increased T cell proliferation. Patients with more sever inﬂammatory
status had lower RTEs of T cells. Content of sj-TREC could be inﬂu-
enced both by age and CAD status. Sj-TREC level from elderly patients
was too low to notice a signiﬁcant difference between SA and NSTACS
patients. Unlike the case with controls and SA patients, content of sj-
TREC was so low in NSTACS patients that it appeared no longer
signiﬁcantly related to age among them. Patients with higher GS had
more complicated plaques and might have poorer thymic function.
Ordinal logistic regression analysis demonstrated that higher sj-TREC
level was an independent protective factor to CAD status. In conclu-
sion, accelerated thymic involution may be partly responsible for the
development of CAD via the alteration of equilibrium of peripheral T
cells compartments and interruption of maintained immune toler-
ance.
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OBJECTIVES Ischemia reperfusion injury is known to impaire cardiac
function in ischemic heart diseases (IHD). Allocryptopine is a botan-
ical alkaloid extracted from Corydalis decumbens (Thunb) Pers Papa-
veraceae. Lately great attention has been paid to its anti-arrhythmic
effects. We hypothesized that allocryptopine can provide protection
against ischemia reperfusion (I/R) injury though reducing transmural
heterogeneity of repolarization in rabbit heart.
METHODS The LADs ligation were conducted to block the blood ﬂow
and reperfuse the myocardium of 48 allocryptopine pretreatment
rabbits. Body-surface electrocardiograms and monophasic action po-
tential (MAP) were recorded before and after acute ischemia and
reperfusion. Transmembrane action potential durations from epicar-
dium, midcardium and endocardium were simultaneously recorded
together with the occurrence of triggered activities and malignant
ventricular arrhythmias.
RESULTS The acute ischemia and subsequent reperfusion shortened
the monophasic actin potential duration (MAPD) of epicardium,
midcardium and endocardium and increased transmural dispersion of
repolarization (TDR) in operation alone group. Treatment of alloc-
ryptopine preferentially prolonged the MAPD50 and MAPD90 of
epicardium and endocardium rather than midcardium, thereby reducethe TDR of ischemia/reperfusion myocardium from 52.38.7 ms/
69.08.0 ms to 30.55.0 ms/ 33.07.0 ms (P ¼0.002). Nine rabbits
were observed early-afterdepolarizations (EADs) and thirteen rabbits
were experienced frequent ventricular tachyarrhythmias during LADs
ligation. Allocryptopine intervention successfully suppressed the I/R-
induced arrhythmias by 35.4% (P ¼0.018).
CONCLUSIONS Allocryptopine maintains the electrophysiological
heterogeneity of repolarization among myocardial layers and effec-
tively prevents I/R induced arrhythmias.
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OBJECTIVES To observe the efﬁcacy and safety of recombinant hu-
man brain natriuretic peptide (rh-BNP) combined with levosimendan
in treating patients with acute myocardial infarction complicated with
heart failure.
METHODS Hospitalized patients who suffered from anterior wall AMI
with heart failure ( KillipIIwIII ) within 12 to 24 hours from the onset
of chest pain were randomized into two groups (n¼30, respectively):
control group (receiving dobutamine and/or cedilanid on the basis of
essential therapy) and experimental group (receiving rh-BNP com-
bined with levosimendan on the basis of essential therapy). The he-
modynamics, clinical parameters of test and adverse events were
observed before and after treatment.
RESULTS In experimental group, compared with those before treat-
ment, there were statistical differences in respiratory rate (RR), heart
rate (HR), systolic blood pressure (SBP), arterial blood gas oxygen
saturation (SaO2), cardiac index (CI), extravascular lung water index
(EVLWI) at 2h and the following time points after treatment(all
P <0.05). In control group, compared with those before treatment,
there were statistical differences in RR, HR, SaO2, CI, EVLWI at 6h
after treatment and in the next time points (all P <0.05). RR, HR, SBP,
SaO2, CI, EVLWI at 2h and 6h after treatment had statistical differ-
ences between two groups, and the differences in RR, HR, CI, EVLWI
persisted for 72 hours after medicine administration. There was a
statistically signiﬁcant difference between two groups in urine vol-
ume, plasma NT-proBNP concentration, left ventricular ejection
fraction (LVEF) and length of stay in CCU (all P <0.05). For adverse
events monitoring, there was no signiﬁcant change between two
groups in hepatic parameters, electrolyte level and coagulation
function before and after treatment.
CONCLUSIONS rh-BNP combined with Levosimendon is superior to
the conventional drugs in improving hemodynamics, increasing urine
volume, decreasing the plasma NT-proBNP concentration, improving
clinical symptoms, increasing LVEF, and reducing the length of stay in
CCU in patients with acute myocardial infarction complicated with
heart failure, which has better tolerance and safety.GW26-e0268
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OBJECTIVES The optimal duration of dual antiplatelet therapy
(DAPT) after percutaneous coronary intervention (PCI) remains
controversial. The present study sought to elucidate the frequency
and predictors of DAPT beyond 12 months after stent deployment in
Chinese population.
METHODS We examined the incidence of extended DAPT at 12
months follow-up among patients after successful PCI enrolled in a
28-site Chinese registry. Predictors of prolonged DAPT beyond 12
months were evaluated using multivariable cox proportional hazards
model.
RESULTS Among 2,130 patients, DAPT was continued in 46% (n¼983)
beyond 12 months after stent implantation. There was a signiﬁcant
heterogeneity of DAPT duration among centers. Compared to those
